Abstract:Due to its rich chemical composition including unique biologically active compounds the gold root (Rhodiola rosea L.) is still of interest to researchers all over the world. However, deficiency of the raw material base and metabolome variability are determination the modern development ways of pharmacologically active substances in vitro obtaining. The article summarizes and systematizes the information about of Rhodiola rosea biologically active compounds obtaining, which are most often obtaining from callus tissues. Callus tissue is usually obtaining from leaf explants, and Murashige and Skoog medium with plant growth regulators in various combinations and concentrations is most commonly used for its induction. At the same time, the tissue growth efficiency and target compounds accumulation depends on the intact plant genotype, the precursors presence of these compounds in the medium, elicitors, as well as external influence factors. Recently, a promising direction is the transgenic hairy roots cultivation, which reveals new aspects of synthesis, accumulation and secondary metabolites production regulation. Biosynthesis genetic regulation of significant secondary metabolites is also a promising direction. Numerous studies have demonstrated that salidroside biosynthesis depends on the expression of the TyrDC gene encoding tyrosinedecarboxylase. Consequently, understanding the molecular and genetic mechanisms opens up opportunities for its regulation and metabolic engineering. In this regard, biotechnological methods may be a priority to obtaining salidroside, rosin and their derivatives at higher or at least comparable levels with wild type or cultivated plants. Among the various biotechnological strategies used to increase the accumulation of salidroside and glycosides of cinnamic alcohol in cells and cultures of Rhodiola organs, the approach with the addition of the metabolic precursors to the nutrient medium proved to be the most effective. In vitro cultures, a significant increase in the production of rosin and its derivatives was observed when precursors (cinnamic alcohol, cinnamic acid and cinnamic aldehyde) were added to the medium.

Biosynthesis of a Rosavin Natural Product in Escherichia Coli by Glycosyltransferase Rational Design and Artificial Pathway Construction.

High-level production of Rhodiola rosea characteristic component rosavin from D-glucose and L-arabinose in engineered Escherichia coli

Alleviation of the Byproducts Formation Enables Highly Efficient Biosynthesis of Rosmarinic Acid in Saccharomyces cerevisiae

One-pot cascade reaction coupling a microbial glycosyltransferase to sucrose synthase for high-level production of cinnamyl alcohol mono-glucoside

Fermentative Production of Phenolic Glucosides by Escherichia Coli with an Engineered Glucosyltransferase from Rhodiola Sachalinensis.

Engineered synthesis of rosmarinic acid in Escherichia coli resulting production of a new intermediate, caffeoyl-phenyllactate

THE OBTAINING RHODIOLA ROSEA L. BIOLOGICALLY ACTIVE COMPOUNDS BY BIOTECHNOLOGICAL METHODS (OVERVIEW)

Metabolic Engineering of Saccharomyces cerevisiae for Rosmarinic Acid Production

Biosynthesis of L-Erythrose by Assembly of Two Key Enzymes in Gluconobacter Oxydans.

Selective Biosynthesis of Retinol in S. Cerevisiae.

Redesign and reconstruction of a steviol-biosynthetic pathway for enhanced production of steviol in Escherichia coli

Enhancing the Accumulation of Rosavins in Rhodiola rosea L. Plants Grown In Vitro by Precursor Feeding

The C4h, Tat, Hppr and Hppd Genes Prompted Engineering of Rosmarinic Acid Biosynthetic Pathway in Salvia Miltiorrhiza Hairy Root Cultures.

High-level De Novo Biosynthesis of Arbutin in Engineered Escherichia Coli

Combinatorial optimization of resveratrol production in engineered E. coli.

Multi-modular engineering of<i>Saccharomyces cerevisiae</i>for high-titre production of tyrosol and salidroside

Metabolic engineering of Escherichia coli for production of salvianic acid A via an artificial biosynthetic pathway

A Novel Biosynthetic Strategy for Ginsenoside Ro: Construction of a Metabolically Engineered Saccharomyces Cerevisiae Strain Using a Newly Identified UGAT Gene from Panax Ginseng As the Key Enzyme Gene and Optimization of Fermentation Conditions

Efficient Biosynthesis of Salidroside Via Artificial in Vivo Enhanced UDP-Glucose System Using Cheap Sucrose As Substrate

Identification of RoCYP01 (CYP716A155) Enables Construction of Engineered Yeast for High-Yield Production of Betulinic Acid

Metabolic Engineering of Escherichia Coli for (2S)-Pinocembrin Production from Glucose by a Modular Metabolic Strategy.